Personalized analysis of metabolic changes in Alzheimer's disease with a systems biology approach

Download

HIBIT22_paper_87.pdf

Date

2022-10

Author

Uzuner, Dilara
Düz, Elif Emanetçi
ilgün, Atılay
Bozkurt, Fatma Betül
Çakır, Tunahan

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

208
views

65
downloads

Alzheimer's disease (AD) is a multifactorial neurodegenerative disease without a cure. Metabolic changes are known to take place in the brains of patients. Metabolic reactions are catalysed by enzymes coded by genes. Therefore, genetic mutations can indirectly affect metabolic changes. Genome scale metabolic models (GEMs) are common tools used in systems biology to understand changes in metabolism. GEMs include all metabolic reactions and reaction-enzyme-gene relationships in the organism. Integrative Metabolic Analysis Tool (iMAT) [1] and Gene Inactivity Moderated by Metabolism and Expression (GIMME) [2] are bioinformatics tools used for integrating gene expression data into GEMs to leverage condition-specific metabolic models. In this study, individual-specific metabolic models were reconstructed by using gene-expression data from the brains of AD and healthy individuals obtained from ROSMAP [3] and Mayo Clinic [4] studies. Totally, 486 AD and 239 healthy samples were analysed separately. In addition, genomic variants were obtained from the transcriptome data for each sample. Among these variants, those that damage protein function was determined, and AD metabolic models were reconstructed by taking into account the effect of these variants. Finally, metabolic reactions whose activity is changed significantly between AD and healthy models were determined. Likewise, the models created by considering the effect of variants were also compared with healthy models. As a result, mechanisms such as fatty acid oxidation, sphingolipid metabolism, and bile acid biosynthesis were found to be affected pathways in both studies. It was also observed that the inclusion of the effect of variants enabled the capture of more AD-associated pathways. It is hoped that these results will be a step in understanding the metabolic changes in AD and will guide the treatment methods.

URI

https://hibit2022.ims.metu.edu.tr
https://hdl.handle.net/11511/101882

Conference Name

The International Symposium on Health Informatics and Bioinformatics

Collections

Graduate School of Informatics, Conference / Seminar

Suggestions

OpenMETU
Core

Gene-level pathogenicity scores for alzheimer’s disease using genomic variants from rna-seq data Bozkurt, Fatma Betül; İlgün, Atılay; Uzuner, Dilara; Çakır, Tunahan (Orta Doğu Teknik Üniversitesi Enformatik Enstitüsü; 2022-10) Alzheimer’s disease (AD) is a complex neurodegenerative disorder affecting millions of people worldwide. Next-generation sequencing technologies such as whole-exome/genome sequencing have been widely used for detecting the variants in the genome to understand the disease etiology and unravel underlying molecular mechanisms. Alternatively, RNA-Seq data can also be used to detect variants. Since AD is a complex disease, several variants are involved in the disease pathogenesis. By using scoring algorithms, it...
Fluorescent labeling of SPOCK1 and localization studies in live neural cell lines Karaboğa, Zeynep Eda; Son, Çağdaş Devrim; Aydın Son, Yeşim; Department of Biology (2022-11-30) Alzheimer's disease is the most common form of dementia and is incurable. The late onset Alzheimer’s disease (LOAD) is associated with complex genetic transition, and the molecular background has not been enlightened yet. Our previous research on the meta-analysis of genome-wide association studies (GWAS) showed a statistical correlation between SPOCK1 variants and LOAD. Also, it is co-regulated with apolipoprotein (APP), one of the proteins clinically linked with LOAD. Furthermore, the SPOCK1 protein ...
COMPARATIVE ANALYSIS OF BRAIN CELL CULTURES AND TISSUES IN ALZHEIMER’S DISEASE BASED ON DIFFERENTIAL EXPRESSION AND GENE SET ENRICHMENT Burduroğlu, Hüseyin Cahit; Aydın Son, Yeşim; Department of Bioinformatics (2023-1-25) Alzheimer’s disease is currently the most common cause of dementia in the world. It is a neurodegenerative disease that is diagnosed neuropathologically by observing B-amyloid plaques and neurofibrillary tangles in the brain. Transcriptional differentiations, protein regulations, and the interactions in between have been investigated by recent studies to understand from which brain cell type the disease stems, such as microglia, astrocytes, and neurons. These studies are mostly performed on brain tiss...
Computer-aided diagnosis of alzheimer’s disease and mild cognitive impairment with MARS/CMARS classification using structural MR images Çevik, Alper; Eyüboğlu, Behçet Murat; Weber, Gerhard Wilhelm; Department of Biomedical Engineering (2017) Early detection of Alzheimer’s disease (AD) and its prodromal stage, amnestic mild cognitive impairment (MCI), has drawn remarkable attention in recent years. Despite the impressive developments in fields of image analysis, pattern classification, and machine learning, no computer-aided diagnosis system has yet been a part of the clinical routine to diagnose the AD. This thesis study aims to propose a thorough procedure which involves detecting the early signs of disease-originated deformations by fully-aut...
Understanding the link between alzheimer’s disease and type 2 diabetesin terms of metabolic alterations Lüleci, Hatice Büşra; Çakır, Tunahan (Orta Doğu Teknik Üniversitesi Enformatik Enstitüsü; 2022-10) UNDERSTANDING THE LINK BETWEEN ALZHEIMER’S DISEASE AND TYPE 2 DIABETES IN TERMS OF METABOLIC ALTERATIONS Hatice Büşra Lüleci, Tunahan Çakır Department of Bioengineering, Gebze Technical University, Kocaeli, Turkey ABSTRACT Alzheimer’s disease (AD) is a type of dementia that causes impairment in memory, reasoning, and thinking. Type 2 diabetes (T2D) is common in the general elderly population and is significantly associated with a higher risk of dementia. However, metabolic alterations responsible for this a...

Citation Formats

D. Uzuner, E. E. Düz, A. ilgün, F. B. Bozkurt, and T. Çakır, “Personalized analysis of metabolic changes in Alzheimer’s disease with a systems biology approach,” Erdemli, Mersin, TÜRKİYE, 2022, p. 3087, Accessed: 00, 2023. [Online]. Available: https://hibit2022.ims.metu.edu.tr.